Home > Journals > Minerva Pneumologica > Past Issues > Minerva Pneumologica 2008 September;47(3) > Minerva Pneumologica 2008 September;47(3):127-42

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

REVIEWS   

Minerva Pneumologica 2008 September;47(3):127-42

Copyright © 2008 EDIZIONI MINERVA MEDICA

language: English

Co-morbidities in pulmonary arterial hypertension

Monteiro B. C., McArdle J. R.

Section of Pulmonary and Critical Care Medicine Yale University School of Medicine New Haven, CT, USA


Full text temporarily not available online. Contact us


Pulmonary arterial hypertension can be idiopathic in nature, or may be associated with any of a variety of co-morbid illnesses, including such disparate conditions as connective tissue disease, congenital heart disease, hemoglobinopathies, HIV infection, portal hypertension, drug or toxin ingestion, thyroid disease and others. There are significant differences between these patient populations in terms of their presentation, hemodynamic parameters, response to therapy and survival. This review explores the similarities and differences in the presentation, pathogenesis, prognosis, and therapeutic options of patients with pulmonary arterial hypertension related to congenital heart disease, connective disease, hemoglobinopathy, thyroid disease, HIV, portal hypertension and drug or toxin induced disease.

top of page